Wanbang Medicine: Net loss of 261,800 yuan in the first quarter of 2026.

Universal Pharmaceutical announced that its revenue for the first quarter of 2026 was 30.5413 million yuan, a year-on-year decrease of 57.02%; net loss was 0.2618 million yuan, compared to a net profit of 11.8493 million yuan in the same period last year.